Privia Health Group Inc (PRVA) Stock: A Closer Look at the Analyst Ratings

ATHA

Privia Health Group Inc (NASDAQ: PRVA) has a price-to-earnings ratio of 250.49x that is above its average ratio. Additionally, the 36-month beta value for PRVA is 0.86. There are mixed opinions on the stock, with 15 analysts rating it as a “buy,” 6 rating it as “overweight,” 2 rating it as “hold,” and 0 rating it as “sell.”

The public float for PRVA is 106.42M and currently, short sellers hold a 4.38% ratio of that float. The average trading volume of PRVA on February 27, 2025 was 606.57K shares.

PRVA) stock’s latest price update

Privia Health Group Inc (NASDAQ: PRVA)’s stock price has increased by 6.61 compared to its previous closing price of 24.06. However, the company has seen a 4.10% increase in its stock price over the last five trading sessions. zacks.com reported 2025-02-27 that Although the revenue and EPS for Privia Health (PRVA) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

PRVA’s Market Performance

Privia Health Group Inc (PRVA) has experienced a 4.10% rise in stock performance for the past week, with a 12.85% rise in the past month, and a 18.97% rise in the past quarter. The volatility ratio for the week is 3.19%, and the volatility levels for the past 30 days are at 3.11% for PRVA. The simple moving average for the past 20 days is 6.76% for PRVA’s stock, with a 30.22% simple moving average for the past 200 days.

Analysts’ Opinion of PRVA

Many brokerage firms have already submitted their reports for PRVA stocks, with Needham repeating the rating for PRVA by listing it as a “Buy.” The predicted price for PRVA in the upcoming period, according to Needham is $25 based on the research report published on January 10, 2025 of the current year 2025.

KeyBanc Capital Markets gave a rating of “Overweight” to PRVA, setting the target price at $23 in the report published on October 11th of the previous year.

PRVA Trading at 15.38% from the 50-Day Moving Average

After a stumble in the market that brought PRVA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -0.08% of loss for the given period.

Volatility was left at 3.11%, however, over the last 30 days, the volatility rate increased by 3.19%, as shares surge +14.97% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +23.83% upper at present.

During the last 5 trading sessions, PRVA rose by +5.03%, which changed the moving average for the period of 200-days by +43.54% in comparison to the 20-day moving average, which settled at $24.04. In addition, Privia Health Group Inc saw 31.20% in overturn over a single year, with a tendency to cut further gains.

Insider Trading

Reports are indicating that there were more than several insider trading activities at PRVA starting from Mountcastle David, who sale 100,000 shares at the price of $25.15 back on Feb 14 ’25. After this action, Mountcastle David now owns 157,727 shares of Privia Health Group Inc, valued at $2,515,000 using the latest closing price.

Mountcastle David, the Officer of Privia Health Group Inc, proposed sale 100,000 shares at $25.15 during a trade that took place back on Feb 14 ’25, which means that Mountcastle David is holding shares at $2,514,838 based on the most recent closing price.

Stock Fundamentals for PRVA

Current profitability levels for the company are sitting at:

  • 0.01 for the present operating margin
  • 0.09 for the gross margin

The net margin for Privia Health Group Inc stands at 0.01. The total capital return value is set at 0.02. Equity return is now at value 2.21, with 1.20 for asset returns.

Based on Privia Health Group Inc (PRVA), the company’s capital structure generated 0.01 points at debt to capital in total, while cash flow to debt ratio is standing at 16.48.

Currently, EBITDA for the company is 27.18 million with net debt to EBITDA at -20.42. When we switch over and look at the enterprise to sales, we see a ratio of 1.55. The receivables turnover for the company is 4.2for trailing twelve months and the total asset turnover is 1.5. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.78.

Conclusion

In conclusion, Privia Health Group Inc (PRVA) has seen better performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.

Most Popular

Related Posts